Arab Pesticides & Veterinary Drugs Mfg Past Earnings Performance
Past criteria checks 3/6
Arab Pesticides & Veterinary Drugs Mfg has been growing earnings at an average annual rate of 13.8%, while the Chemicals industry saw earnings growing at 10.4% annually. Revenues have been growing at an average rate of 8.7% per year. Arab Pesticides & Veterinary Drugs Mfg's return on equity is 14.3%, and it has net margins of 14.9%.
Key information
13.8%
Earnings growth rate
13.2%
EPS growth rate
| Chemicals Industry Growth | 13.1% |
| Revenue growth rate | 8.7% |
| Return on equity | 14.3% |
| Net Margin | 14.9% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Arab Pesticides & Veterinary Drugs Mfg makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 31 | 5 | 4 | 0 |
| 31 Dec 23 | 30 | 4 | 4 | 0 |
| 30 Sep 23 | 28 | 4 | 3 | 0 |
| 30 Jun 23 | 27 | 4 | 3 | 0 |
| 31 Mar 23 | 26 | 4 | 3 | 0 |
| 31 Dec 22 | 24 | 4 | 3 | 0 |
| 30 Sep 22 | 23 | 4 | 3 | 0 |
| 30 Jun 22 | 23 | 4 | 3 | 0 |
| 31 Mar 22 | 22 | 4 | 3 | 0 |
| 31 Dec 21 | 23 | 4 | 3 | 0 |
| 30 Sep 21 | 22 | 4 | 3 | 0 |
| 30 Jun 21 | 22 | 4 | 3 | 0 |
| 31 Mar 21 | 24 | 4 | 3 | 0 |
| 31 Dec 20 | 23 | 3 | 3 | 0 |
| 30 Sep 20 | 23 | 3 | 3 | 0 |
| 30 Jun 20 | 23 | 3 | 3 | 0 |
| 31 Mar 20 | 20 | 2 | 3 | 0 |
| 31 Dec 19 | 20 | 2 | 3 | 0 |
| 30 Sep 19 | 19 | 2 | 3 | 0 |
| 30 Jun 19 | 18 | 2 | 3 | 0 |
| 31 Mar 19 | 18 | 2 | 3 | 0 |
| 31 Dec 18 | 17 | 2 | 3 | 0 |
| 30 Sep 18 | 16 | 2 | 3 | 0 |
| 30 Jun 18 | 17 | 2 | 3 | 0 |
| 31 Mar 18 | 17 | 2 | 3 | 0 |
| 31 Dec 17 | 17 | 2 | 3 | 0 |
| 30 Sep 17 | 17 | 2 | 3 | 0 |
| 30 Jun 17 | 17 | 2 | 3 | 0 |
| 31 Mar 17 | 19 | 2 | 3 | 0 |
| 31 Dec 16 | 20 | 2 | 3 | 0 |
| 30 Sep 16 | 21 | 2 | 3 | 0 |
| 30 Jun 16 | 20 | 2 | 3 | 0 |
| 31 Mar 16 | 19 | 2 | 2 | 0 |
| 31 Dec 15 | 19 | 2 | 2 | 0 |
| 30 Sep 15 | 19 | 1 | 2 | 0 |
| 30 Jun 15 | 20 | 2 | 2 | 0 |
| 31 Mar 15 | 20 | 1 | 2 | 0 |
| 31 Dec 14 | 21 | 2 | 2 | 0 |
| 30 Sep 14 | 21 | 2 | 2 | 0 |
| 30 Jun 14 | 21 | 2 | 2 | 0 |
| 31 Mar 14 | 22 | 3 | 2 | 0 |
| 31 Dec 13 | 21 | 2 | 2 | 0 |
| 30 Sep 13 | 22 | 2 | 2 | 0 |
| 30 Jun 13 | 20 | 2 | 2 | 0 |
Quality Earnings: MBED has high quality earnings.
Growing Profit Margin: MBED's current net profit margins (14.9%) are lower than last year (15.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MBED's earnings have grown by 13.8% per year over the past 5 years.
Accelerating Growth: MBED's earnings growth over the past year (11.5%) is below its 5-year average (13.8% per year).
Earnings vs Industry: MBED earnings growth over the past year (11.5%) exceeded the Chemicals industry -13.9%.
Return on Equity
High ROE: MBED's Return on Equity (14.3%) is considered low.